TherapeuticsMD (TXMD) Other Accumulated Expenses (2010 - 2025)

TherapeuticsMD (TXMD) has reported Other Accumulated Expenses for 16 consecutive years, with $301000.0 the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Other Accumulated Expenses changed N/A year-over-year to $301000.0; the trailing twelve-month figure through Sep 2025 stood at $301000.0 (changed N/A YoY), and the FY2024 full-year result was $88000.0, down 78.48% from the prior year.
• Other Accumulated Expenses climbed to $301000.0 in Q3 2025 per TXMD's latest filing, from $202000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $59.2 million in Q2 2022 and bottomed at $88000.0 in Q4 2024.
• Historically, Other Accumulated Expenses has averaged $16.2 million across 5 years, with a median of $11.5 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Other Accumulated Expenses soared 580.86% in 2021, then slumped 97.83% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $13.3 million in 2021, then soared by 41.3% to $18.8 million in 2022, then plunged by 97.83% to $409000.0 in 2023, then plunged by 78.48% to $88000.0 in 2024, then soared by 242.05% to $301000.0 in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $301000.0, $202000.0, and $249000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.